Myocardial Infarction
Many adults would forgo care for serious symptoms to avoid SARS-CoV-2 exposure, survey finds
One in 6 adults would waive care for myocardial infarction symptoms and 1 in 4 would waive care for appendicitis symptoms to avoid exposure to COVID-19, according to survey results published in JAMA Network Open.
Implantable cardiac monitor improves arrhythmia detection in high-risk patients post-MI
In high-risk patients with a prior MI and cardiac autonomic dysfunction, use of an implantable cardiac monitor increased the detection rate of serious arrhythmic events compared with conventional follow-up.
New REDUCE-IT analysis shows benefits of icosapent ethyl in patients with prior MI
In patients with prior MI from the REDUCE-IT cohort, icosapent ethyl reduced risk for first and total CV events compared with placebo, according to new data presented at the European Society of Cardiology Congress.
LoDoCo2: Colchicine benefits consistent regardless of ACS history, timing
In patients with chronic coronary disease, the beneficial effects of colchicine were consistent regardless of history of ACS and time of treatment following ACS, according to new data from the LoDoCo2 trial.
Vitamin D sufficiency may reduce MI, all-cause mortality risk in primary prevention
Treating to a vitamin D level of at least 30 ng/mL is associated with significantly lower risk for myocardial infarction and all-cause mortality among adults with no prior MI history, according to an analysis of Veterans Affairs data.
Conservative management effective in patients with stable angina
Most patients with stable CAD and anginal symptoms experienced improvement in angina over time without any changes to antianginal therapy or need for coronary revascularization, according to results from the CLARIFY registry.
Beta-blocker therapy beyond 1 year after MI fails to improve survival
Beta-blocker therapy did not improve survival beyond 1 year after an MI, although a dose-dependent effect was observed, according to findings from a landmark analysis of the OBTAIN registry.
PCI rates down 10% during 8-year period
After a significant decline in elective PCIs performed from 2010 to 2013, rates of the procedure remained stable through 2017, resulting in a roughly 10% decline in PCIs performed during the 8-year period, researchers reported.
Testosterone therapy may reduce CV events, mortality in men with very low hormone levels
Long-term testosterone therapy significantly reduced MI and stroke events in men with abnormally low testosterone levels, according to new data presented at the European Association of Urology Congress.
MINOCA not benign, should be treated as a syndrome
Patients with MI or ischemia without obstructive CAD are at elevated risk for poor CV outcomes and doctors need to pinpoint the cause of ischemia, according to a speaker.